Welcome : Guest

Emergent Bio Solutions, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Emergent Bio Solutions, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 44 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64262
Price: $2200
Company Type: Public
Pages: 51
Date: November 2016
Market Data Tables: 44

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Emergent Biosolutions, Inc.’s Sales by Product Segment (2014-2015) in Percentage for Biodefense, and Biosciences......3
Vaccines......9
Table 2: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......9
Immunoglobulin......10
Table 3: Immunoglobulin Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flebogamma, Gammagard Liquid, Gamunex, Octagam, Privigen and Others......10
Table 4: Immunoglobulin (IG) Consumption by Country Worldwide (2015) - Percentage Market Share Breakdown by Volume for Australia, Canada, China, France, Germany, Italy, Japan, UK, USA, and Others......11
Table 5: Immune Globin Usage Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Immune Thrombocytopenia (ITP), Primary Immune Deficiency (PID), Other Central Nervous System (CNS) and Others......12
Intravenous and Subcutaneous Immunoglobulin (IVIG & SCIG)......13
Table 6: Intravenous Immunoglobulin (IVIG) Usage by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Hematology and Oncology, Immune Thrombocytopenic Purpura (ITP), Neurology, Pelvic Inflammatory Disease (PID), and Others......13
Table 7: Intravenous Immunoglobulin (IVIG) Market by Region Worldwide (2015) - Percentage Market Share Breakdown by Volume Sales for Australia, Canada, Europe (East & West) and New Zealand, US, Others (Excluding US (Including Japan))......14
Table 8: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales, for Europe, US, and Others......15
Table 9: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume Sales, for Europe, US, and Others......16
Table 10: Intravenous and Subcutaneous Immunoglobulin (IVIG & SCIG) Market by Indication in the US (2015) - Percentage Share Breakdown by Volume for CIDP (Chronic Inflammatory Demyelinating Polyneuropathy), CLL (Chronic Lymphocytic leukaemia), ITP (Idiopathic Thrombocytopenic Purpura), MMN (Multifocal Motor Neuropathy), PID (Primary Immune Deficiency) and Others......17
Table 11: Intravenous Immunoglobulin (IVIG) Therapy by Disorders in the US (2015) - Percentage Market Share Breakdown by No. of Indications for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Chronic Lymphocytic Leukemia (CLL), Idiopathic Thrombocytopenic Purpura (ITP), Mismatch Negativity (MMN), Pelvic Inflammatory Disease (PID), and Others......18
Factor IX (FIX)......19
Table 12: Factor IX (FIX) Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Plasma-Derived FIX (PD FIX) and Recombinant FIX (r-FIX)......19
Table 13: Factor IX (FIX) Consumption by Category Worldwide (2015) - Percentage Market Share Breakdown by Volume for Plasma-Derived FIX (PD FIX) and Recombinant FIX (r-FIX)......20
Table 14: Factor IX (FIX) Sales by Category in the US (2015) - Percentage Market Share Breakdown by Value for Plasma-Derived FIX (PD FIX) and Recombinant FIX (r-FIX)......21
Table 15: Factor IX (FIX) Consumption by Category in the US (2015) - Percentage Market Share Breakdown by Volume for Plasma-Derived FIX (PD FIX) and Recombinant FIX (r-FIX)......22
Plasma Products......23
Table 16: Plasma Market by Product Worldwide (2015) - Percentage Breakdown by Value for Albumin, Factor IX, Factor VIII, Hyperimmunes, Intravenous Immunoglobulin (IVIG), and Others......23
Table 17: Plasma Derivatives Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Albumin, Alpha-1 Proteinase Inhibitor (A1PI), Hyperimmune, Intravenous Immunoglobulin (IVIG), Plasma-Derived Factor VIII (PDFVIII) & Willebrand Factor (WFactor), Polymeric Immunoglobulin Receptor, and Others......24
Table 18: Plasma Products Consumption by Type in China (2015) - Percentage Share Breakdown by Volume for Albumin, Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG)......25
Table 19: Plasma-Based Product Market by Type in China (2015) - Percentage Share Breakdown by Value for Blood Coagulation Factor, Human Albumin, Human Immunoglobin, Hyperimmunes, and Others......26
Table 20: Plasma Market by Type in China (2015) - Percentage Share Breakdown by Value for Blood Coagulation Factor, Fibrinogen, Human Albumin, Human Immunoglobin and Hyperimmunes and Other......27
Table 21: Plasma Products Consumption by Type in the US (2015) - Percentage Share Breakdown by Volume for Albumin, Factor IX (Plasma), Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG), and Others......28
Hemophilia Treatment......29
Table 22: Hemophilia Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hemophilia A, Hemophilia B, Inhibitor, and Von Willebrand Disease......29
Vaccines......30
Table 23: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......30
Diphtheria and Tetanus Vaccines......31
Table 24: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......31
Hepatitis A Vaccines......32
Table 25: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......32
Hepatitis B (Recombinant) Vaccines......33
Table 26: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......33
Hepatitis A and Typhoid Polysaccharide Vaccines......34
Table 27: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......34
Human Papillomavirus Vaccines......35
Table 28: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......35
Human Rotavirus Vaccines......36
Table 29: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......36
Influenza Vaccines......37
Table 30: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......37
Measles, Mumps and Rubella Vaccines......38
Table 31: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......38
Tetanus Toxoid, reduced Diphthera Vaccines......39
Table 32: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......39
Typhoid Vaccines......40
Table 33: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......40
Varilrix Vaccines......41
Table 34: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......41
Table 35: Market Shares of Leading Immunoglobulin Providing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Baxter International, Inc. (Gammagard Liquid and S/D), CSL Limited (Privigen, Carimune and Hizentra), Grifiols, S.A. (Flebogamma and Gamunex) and Others......42
Table 36: Market Shares of Leading Immunology/ Immunoglobulin Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., and Others......43
Hepatitis B Immune Globulin......44
Table 37: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co., Ltd., Ningbo Boya Medical Equipment Co., Ltd., Shuyang Group, Tonrol Biopharm Co., Ltd., and Others......44
Human Immunoglobulin......45
Table 38: Market Shares of Leading Human Immunoglobulin Providers in China (2015) - Percentage Share Breakdown by Value for China Biologic Products, Inc., China National Biotec Group, Huanlan Biological Engineering, Inc., and Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.......45
Intravenous Immunoglobulin (IVIG)......46
Table 39: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Producers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A, LFB Group, Octapharma AG, and Others......46
Table 40: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A., Octapharma AG and Others......47
Table 41: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Therapy Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Biotest AG, CSL Limited, Grifols, S.A., Talecris Biotherapeutics, Inc., Kedrion S.p.A., Octapharma AG, and Others......48
Table 42: Market Shares of Leading Intravenous immunoglobulin (IVIG) Manufacturers in China (2015) - Percentage Breakdown by Value for Chengdu Institute of Biological Products Co., Ltd., China Biologic Products, Inc., Hualan Biological Engineering, Inc., Shanghai Institute of Biological Products Co., Ltd., Shanxi Kangbao Biological Product Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. and Others......49
Table 43: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in Europe (2015) - Percentage Breakdown by Value for Baxter International Inc., Biotest AG, CSL Ltd., Grifols, S.A (Incl.Talecris), Octapharma AG, and Others......50
Table 44: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Ltd., Grifols, S.A (Incl.Talecris), and Others......51